Cue Health Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net (loss) income
Adjustments to reconcile net (loss) income to net cash, cash equivalents and restricted cash used in operations
Depreciation and amortization
(Recoveries) allowance for credit losses provision
Change in fair value of redeemable convertible preferred stock warrant liabilities
Change in fair value of convertible notes
Stock-based compensation expense
Loss on extinguishment of debt
Non-cash lease expense
Convertible notes issuance costs
Deferred income taxes
Interest on finance leases
Stock-based compensation expense from issuance of fully vested warrant to vendor
Non-cash interest expense
Impairment of long-lived assets
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other non-current assets
Accounts payable, accrued liabilities and other current liabilities
Income taxes payable
Deferred revenue
Operating lease liabilities
Other non-current liabilities
Net cash, cash equivalents and restricted cash used in operating activities
Cash flows from investing activities
Purchases of property and equipment
Expenditures for software development and other intangible assets
Net cash, cash equivalents and restricted cash used in investing activities
Cash flows from financing activities
Proceeds from issuance of Series C-1 redeemable convertible preferred stock
Proceeds from convertible notes
Payments for issuance costs of Series C-1 redeemable convertible preferred stock
Proceeds from exercise of redeemable convertible preferred stock warrant
Payments of issuance costs of convertible notes
Proceeds from exercise of common stock options
Proceeds from exercise of common stock warrant
Proceeds from issuance of common stock at public offering
Payments of issuance costs of public offering
Proceeds from debt
Tax withholding on exercise of stock options and restricted stock units
Proceeds from employee stock purchase plan activity
Debt issuance and prepayment costs
Repayment of debt
Payments for finance leases
Net cash, cash equivalents and restricted cash (used in) provided by financing activities
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning balance
Cash, cash equivalents and restricted cash, ending balance
Supplemental disclosure for cash flow information
Cash paid for taxes
Cash paid for interest
Supplemental disclosure for non-cash investing and financing matters
Early exercised stock options liability
Conversion of convertible notes to Series C-2 redeemable convertible preferred stock
Right-of-use assets obtained in exchange for lease obligations
Prepaid rent reclassified to right-of-use assets
Purchases of property and equipment included in accounts payable and accrued liabilities
Software development costs included in accounts payable
Conversion of redeemable convertible preferred stock into common stock
Exercise of redeemable convertible preferred stock warrant
Equipment obtained under capital lease obligations
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents
Restricted cash, current
Restricted cash, non-current

Comments